KEAP1 anticorps (C-Term)
Aperçu rapide pour KEAP1 anticorps (C-Term) (ABIN6990770)
Antigène
Voir toutes KEAP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- At least two isoforms of KEAP1 are known to exist.
-
Purification
- KEAP1 Antibody is affinity chromatography purified via peptide column.
-
Immunogène
- Anti-KEAP1 antibody was raised against a 19 amino acid synthetic peptide near the carboxy terminus of human KEAP1. The immunogen is located within the last 50 amino acids of KEAP1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1-2 μ,g/mL, IF: 20 μ,g/mL.
Antibody validated: Western Blot in human, mouse and rat samples, Immunofluorescence in human samples. All other applications and species not yet tested. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- KEAP1 Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,4 °C
-
Stockage commentaire
- KEAP1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- KEAP1 (Kelch-Like ECH-Associated Protein 1 (KEAP1))
-
Autre désignation
- KEAP1
-
Sujet
- KEAP1 Antibody: KEAP1 (kelch-like ECH-associated protein 1) is a stress sensing adaptor for the Cullin3 (Cul3)-dependent E3 ubiquitin ligase complex that negatively regulates NRF2 (NF-E2-related factor 2) and plays a role in the oxidative stress response. It targets NFE2L2/NRF2 for ubiquitination and degradation by the proteasome. KEAP1 contains an amino terminal BTB/POZ domain and a carboxyl terminal KELCH domain which are required for interaction with NRF2, and in binding Cul3-E3 ubiquitin ligase. Altered expression of NRF2 is associated with chronic obstructive pulmonary disease (COPD). KEAP1 also targets the down regulation of NF-κ,B activity by targeting IKKβ, degradation. Mutation of the KEAP1 gene is found in lung cancer.
-
Poids moléculaire
-
Predicted: 70kD
Observed: 65-70kD kDa -
ID gène
- 9817
-
NCBI Accession
- NP_987096
-
UniProt
- Q14145
-
Pathways
- Maintenance of Protein Location
Antigène
-